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Abstract
Background:  Chorioamnionitis is a common underlying cause of preterm birth (PTB). It is
hypothesised that polymorphisms in immunoregulatory genes influence the host response to
infection and subsequent preterm birth. The relationship between histologic chorioamnionitis and
22 single nucleotide polymorphisms in 11 immunoregulatory genes was examined in a case-control
study.
Methods: Placentas of 181 Caucasoid women with spontaneous PTB prior to 35 weeks were
examined for histologic chorioamnionitis. Polymorphisms in genes IL1A, IL1B, IL1RN, IL1R1, tumour
necrosis factor (TNF), IL4, IL6, IL10, transforming growth factor beta-1 (TGFB1), Fas (TNFRSF6), and
mannose-binding lectin (MBL2) were genotyped by polymerase chain reaction and sequence
specific primers. Multivariable logistic regression including demographic and genetic variables and
Kaplan-Meier survival analyses of genotype frequencies and pregnancy outcome were performed.
Results: Sixty-nine (34%) women had histologic evidence of acute chorioamnionitis. Carriage of
the IL10-1082A/-819T/592A (ATA) haplotype [Multivariable Odds ratio (MOR) 1.9, P = 0.05] and
MBL2 codon 54Asp allele (MOR 2.0, P = 0.04), were positively associated with chorioamnionitis,
while the TNFRSF6-1377A/-670G (AG) haplotype (MOR 0.4, P = 0.03) and homozygosity for TGFB1-
800G/509T (GT) haplotype (MOR 0.2, P = 0.04) were negatively associated.
Conclusion: These findings demonstrate that polymorphisms in immunoregulatory genes IL10,
MBL2, TNFRSF6 and TGFB1 may influence susceptibility to chorioamnionitis.
Background
Acute infection of the amniotic fluid and chorioamnion is
a common cause of preterm delivery before 34 weeks ges-
tation. Consistent with previous reports [1], an Australian
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study found that 31% of preterm births (PTB) before 34
weeks had histologic chorioamnionitis [2]. An inverse
relationship between delivery gestation and histologic
chorioamnionitis was shown with histologic chorioamni-
onitis identified in 66% of births before 25 weeks. Chori-
oamnionitis usually results from ascent of pathogenic
organisms such as Group B streptococcus and Escherichia
coli [3], from the lower genital tract. A T helper cell type1
(Th1) cytokine host response occurs with the production
of pro-inflammatory cytokines such as (IL-1β  and TNF)
produced mainly by activated monocytes/macrophages in
amnion, chorionic and decidual tissue. The increased lev-
els of these cytokines trigger prostaglandin F2 and E2 bio-
synthesis by the decidua and amnion, inducing uterine
contractions and labour [4]. In the setting of infection, IL-
1 and TNF have a synergistic effect on the acute phase
cytokine IL-6 with increased production in trophoblasts
and chorion and to a lesser extent decidua [5]. The inten-
sity and duration of the inflammatory response is modu-
lated by T helper cell type 2 cytokines and anti-
inflammatory mediators such as IL-4, IL-10, IL-1 receptor
antagonist (IL-1ra) and transforming growth factor beta-1
(TGFβ -1).
The innate host defense system is also an important factor
in pregnancy and the body's response to infection. Man-
nose-binding lectin (MBL), a protein of the complement
system, opsonises pathogens independently of antibody
for phagocytosis and influences inflammatory pathways
[6]. There are several common polymorphisms in the pro-
moter and coding region of the MBL2  gene that pro-
foundly influence circulating levels of functional,
multimeric MBL. These genetic variants and low MBL lev-
els are associated with risk and severity of infection in a
variety of clinical contexts [6].
Fas, a cell surface receptor of the TNF/nerve growth factor
superfamily, mediates apoptosis after binding Fas ligand
[7]. Activated leucocyte populations, including T cells,
express high amounts of Fas and evidence suggests that
trophoblast Fas-mediated apoptosis is increased in
women with chorioamnionitis [8].
The immune system operates as a complex regulatory net-
work of cytokines and other mediators with a degree of
redundancy that changes as pregnancy progresses [9]. This
makes it difficult to assess the importance of single
cytokines in inflammation and response to infectious
agents when examined in isolation. The genes encoding
these mediators contain coding and non-coding polymor-
phisms that influence level or function of the encoded
mediators [10]. These polymorphisms may influence sus-
ceptibility to chorioamnionitis and adverse pregnancy
outcome. Single nucleotide polymorphisms (SNPs) for
IL1 +3953 and TNF -308 are associated with human cho-
rioamnionitis in in vitro studies [11] and carriage of the
TNF -308 A allele has been reported as a risk factor for
clinical chorioamnionitis in pregnant women [12]. How-
ever these reports were restricted to small numbers of
cytokine genes and did not include the analysis of poly-
morphisms in molecules important in apoptosis and host
defence. Examination of a range of immunoregulators
and SNPs concurrently is more likely to identify which
genes and alleles are of primary importance in response to
intra-uterine infection.
We hypothesized that polymorphisms in immunoregula-
tory genes may influence susceptibility to chorioamnioni-
tis and subsequent preterm labour. To examine this
hypothesis, we investigated multiple polymorphisms in
immunoregulatory genes in a population of Australian
Caucasoid women experiencing spontaneous PTB before
35 weeks and histologic chorioamnionitis.
Methods
This case-control study was approved by the Women's and
Children's Hospital Ethics and Research Committee. A
total of 368 unrelated women of child-bearing age who
had obstetric management at the Women's and Children's
Hospital (WCH) and history of PTB before 35 weeks ges-
tation were identified from the hospital data base. All
women were approached in the first instant by letter of
introduction and invited to participate in the study. For
women living in the Adelaide metropolitan area, the
study nurse made a home visit to those who volunteered
for eligibility assessment. Geographical distance excluded
50, 66 did not respond, 40 were not eligible and 31
declined. Of the women enrolled some had more than
one PTB. The PTB fitting the study criteria and closest to
the enrolment date became the index birth. Written con-
sent was obtained and a 9 ml peripheral blood sample
was collected for isolation of leucocytes and DNA extrac-
tion. 181 women with a history of spontaneous preterm
labour and subsequent PTB between 20 and 35 weeks in
the index pregnancy had histological examination of the
placenta performed. Histopathology staff members were
unaware of the genetic results.
Clinical data recorded included gestational age at delivery
(calculated by ultrasonography at approximately 18
weeks). Obstetric factors known to place a woman at risk
of preterm labour or preterm prelabour rupture of mem-
branes (PPROM) (defined as prelabour rupture of mem-
branes 3 or more hours before preterm delivery) were also
recorded. Placental examination and swabbing was per-
formed by staff histopathologists [13] and included exam-
ination of the placental tissue in blocks, extra-placental
membranes in a "roll" (amnion, chorion and decidua)
and the umbilical cord in cross section. Chorioamnionitis
was defined as a dense polymorphonuclear leukocyteBMC Pregnancy and Childbirth 2005, 5:4 http://www.biomedcentral.com/1471-2393/5/4
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infiltration of the chorionamniotic component of the pla-
centa and membranes (amnion, chorion, amniochorial
membranes and/or chorionic plate (top part of the fetal
side of the placenta). Inflammatory reaction confined to
either the decidua or subchorial intervillous space of the
placental disc, without infiltration of the chorion or
amnion was recorded as negative chorioamnionitis [3].
Funisitis was defined as inflammation in one or more of
the umbilical cord vessels (vasculitis) with or without
inflammation in the Wharton's jelly (the supporting soft
tissue around the vessel in the cord). The definition of
acute chorioamnionitis included funisitis and/or amnio-
nitis. In both groups a number of women had PPROM,
occasional bleeding during pregnancy, recorded clinical
chorioamnionitis or a history of prior term births. Toco-
lytic therapy and intravenous antibiotics were used
according to obstetric protocols. All participants were
Caucasoid, unrelated and at least 18 years of age at enrol-
ment. Women with diagnosed autoimmune disease, pre-
eclampsia, in vitro fertilisation treatment, confirmed uter-
ine malformations, no spontaneous labour, ultrasound-
confirmed fetal abnormality, insulin dependent diabetes,
or multiple pregnancy were excluded.
Demographic characteristics, a comprehensive medical
and obstetric history, age, any smoking, alcohol con-
sumption, substance use and clinical chorioamnionitis
(defined as any three of the following – white blood cell
>1500 × 10^9/L, three consecutive C reactive protein
readings ≥  15mg/L, pyrexia ≥  38°C, uterine pain or ten-
derness) were verified from case records. Clinical chorio-
amnionitis was not used as a subgroup for polymorphic
analysis because this did not include women with sub-
clinical infection. Since the risk of chorioamnionitis is not
as great in PTB after 35 weeks, women with PTB between
35 and 37 weeks were not enrolled [2].
Genes were chosen if reported to be associated with
inflammatory disease[10] and if existing functional data
suggested a role in chorioamnionitis and preterm deliv-
ery[5,11]. SNPs were selected where the minor allele has a
frequency >10%. Several genes were known to contain
polymorphisms at multiple sites that are of functional
importance (e.g. the 5'and coding variants of MBL2) [14],
thus multiple variants were genotyped and the haplotype
recorded. SNPs in the IL1 gene cluster, TNF, IL4, IL6, IL10,
TGFB1, TNFRSF6, and MBL2 genes and their relationship
with histologic chorioamnionitis were therefore exam-
ined in a cohort of women with spontaneous PTB.
Peripheral blood samples were blinded and tested at the
Australian Red Cross Blood Service, Adelaide (ARCBS).
Genomic DNA was extracted from ethylenediamine-
tetraacetic acid anticoagulated venous blood using stand-
ard methods as previously described [15]. SNPs for TNF
(+488,-238,-308) [16], IL1A (-889), IL1B (+3962, -511),
IL4 (-590), IL10 (-1082, -819, -592), TGFB1 (-800, -509)
[17], MBL2 [-550, -221, codon 52 (Arg →  Cys), codon 54
(Gly →  Asp), codon 57 (Gly →  Glu)] [18], IL6 (-174), IL-
1 receptor antagonist IL1RN (+11100), IL-1 type 1 recep-
tor IL1R1 (+970) and TNFRSF6 (-1377, -670) [19] were
genotyped using the polymerase chain reaction and
sequence specific primers (PCR-SSP). Multiple polymor-
phisms were examined in the IL10, TNFRSF6, TNF, TGFB1
and MBL2 genes by PCR haplotyping. The term "haplo-
type" denotes ordered combination of alleles on a single
chromosome, and is used where multiple polymorphisms
are genotyped by PCR-haplotyping for a single gene. For
PCR haplotyping combinations of forward and reverse
allele-specific-primers were used to directly amplify alleles
on the same chromosome [20]. This technique also pro-
vides a degree of redundancy, in that multiple reactions
genotype a polymorphism, thus confirming results. All
PCR-SSP reactions have been extensively used in the same
laboratory. Internal control primers for conserved regions
of the DRB1 (major histocompatibility complex, class 11
DR beta 1) and APC (adenomatous polyposis coli) genes
were included in every PCR mix to verify successful ampli-
fication. All genes except the IL1A had a repeat genotyping
rate of less than 1%. The IL1A had a repeat rate of 10%.
The sample size was calculated by using the statistical soft-
ware package EpiInfo 6 (Version 6.04d, Centre for Disease
Control and Prevention, Atlanta, GA). We estimated the
study had sufficient power (1-β  = 80%, P = 0.05) to detect
a minimum of 17% difference in genotype frequency
between chorioamnionitis and no chorioamnionitis for
frequencies of approximately 10% (ie. 10% versus 27%).
For a genotype frequency of 3% the minimum detectable
difference was 10% (3% versus 13%). Allele and haplo-
type frequencies for polymorphisms were determined by
direct counting from each chromosome. Frequencies of
genetic variants were recorded as allele (proportion of
positive chromosomes), genotype (proportion possessing
homozygous or heterozygous combinations of alleles),
and 'carriage' of an allele or haplotype (either in
homozygous or heterozygous state). Alleles were said to
be in Hardy-Weinberg equilibrium if the observed geno-
type frequencies did not differ significantly (P > 0.05)
from those expected when analysed by Chi square. Gene
variant frequencies were compared using 2 × 2 contin-
gency table analysis and the Chi square test for independ-
ence using EpiInfo 6. Mean birth weights were compared
by t-test.
Multivariable analysis was performed by stepwise back-
wards multiple logistic regression using SYSTAT 9.0 soft-
ware (Systat version 1999 SPSS Inc). The basic model
included genetic variables with P values < 0.15 obtained
in univariate analyses. In each multivariable model, onlyBMC Pregnancy and Childbirth 2005, 5:4 http://www.biomedcentral.com/1471-2393/5/4
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one genotype or haplotype of each gene was selected for
analysis. Selection of genotype/haplotype for the model
was based on strength of association, the previously
reported importance of a gene variant and homozygosity
of alleles. At each backward step in the regression analysis
P values ≥  0.07 were rejected. Kaplan-Meier survival anal-
ysis (SYSTAT 9.0) was used to identify cumulative proba-
bility in maintaining pregnancy by gestation stratified by
chorioamnionitis and gene variables. Breslow-Gehan Chi
square was used to weight each gestational period by the
total number at risk at that time so that earlier gestations
receive greater weight than later gestations.
Results
Sixty-nine (38%) women had histologic evidence of acute
chorioamnionitis, and 112 (62%) had no such evidence.
There were no significant differences between those with
and without histologic chorioamnionitis for maternal
age, race, history of smoking, alcohol consumption, sub-
stance use, new partner, cervical cerclage, placenta praevia
after 22 weeks with bleeding, history of two or more PTBs
before 35 weeks, miscarriage between 12 and 20 weeks or
PPROM (Table 1). Histologic chorioamnionitis was posi-
tively associated with clinical chorioamnionitis [Univari-
ate Odds Ratio (OR) 6.1, 95% Confidence Intervals (CI)
2.4–17, uncorrected P ≤  0.0001], PTB before 29 weeks
(OR 7.6, CI 3.4–18, P ≤  0.0001) and positive placental
culture (OR 3.0, CI 0.9–11, P = 0.04).
All alleles were in Hardy-Weinberg equilibrium. All gene
variants were tested for associations between the two
groups. In preterm women without histologic chorioam-
nionitis frequencies for the IL10-1082A/-819T/-592A
(ATA) haplotype [17], MBL2 codon 54Asp (the MBL 'B'
allele) [21], TNFRSF6-1377A/-670G (AG) haplotype [22]
and  TGFB1-800G/-509T (GT) homozygosity [17] were
similar to reported Caucasian controls.
In a comparison of women with chorioamnionitis and
those without chorioamnionitis a comprehensive listing
of gene carriage, alleles, genotype and haplotype frequen-
cies is provided (Additional file 1). Univariate analysis
revealed that carriage of the IL10-1082A/-819T/-592A
(ATA) haplotype (present in 49% of women with
Table 1: Demographic and clinical characteristics of women with preterm birth before 35 weeks.
Variable Histologic Chorio-
amnionitis n = 69
No Histologic Chorio-
amnionitis n = 112
Significant OR (95% CI), 
and Uncorrected P values
Maternal age (years) 29 (16–41) 30 (17–44)
Delivery gestation (weeks) 28 (20–34) 30 (23–34) *
Mean birth weight 1399 (± 676) 1897 (± 504) < 0.0001
Maternal age ≥  35 years 11 (16%) 18 (16%) ns
Maternal age ≤  17 years 2 (3%) 2 (2%) ns
Any smoking 22 (31%) 29 (26%) ns
Any alcohol 44 (64%) 73 (65%) ns
Any substance use 7 (10%) 10 (9%) ns
Partner change for 14 (20%) 20 (18%) ns
pregnancy
Cervical cerclage 3 (4%) 2 (2%) ns
Previous mid-trimester 4 (6%) 12 (11%) ns
miscarriage (12–20 weeks)
2 or more preterm births 11 (16%) 20 (18%) ns
Placenta praevia after 22 weeks with bleeding 1 (1%) 2 (2%) ns
Documented clinical chorioamnionitis 22 (32%) 8 (7%) 6.1 (2.4–17), < 0.001
PPROM ≥  3 hours 39 (57%) 74 (66%) ns
Gestation < 29 weeks 33 (48%) 12 (11%) 7.6 (3.4–18), < 0.001
Documented positive
placental culture 10 (14%) 6 (5%) 3.0 (0.9–11), 0.04
Neonatal sepsis 10 (14%) 0 19 (3 – 823), < 0.001
Neonatal death 6 (9%) 3 (3%) ns
Post partum endometritis 5 (7%) 3 (3%) ns
Descriptive statistical results are mean (± SD) or number (%) as appropriate, and maternal age and gestation as median (range). Characteristics are 
from index birth. PPROM = Preterm premature rupture of membranes 3 hours or more before delivery < 35 weeks.
Univariate analyses were tested using Chi square analysis of 2 × 2 table, and uncorrected P values, Odds Ratio (OR), and 95% Confidence Intervals 
(CI), P values ≤  0.05 are presented. Mean birth weights were tested by two-sample t-test, assuming unequal variances.
* See Figure 1,
ns, not significant.BMC Pregnancy and Childbirth 2005, 5:4 http://www.biomedcentral.com/1471-2393/5/4
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chorioamnionitis vs 33% without chorioamnionitis, OR
2.0, P = 0.03) and the IL10-819T and -592A alleles (50%
versus 33%, OR 2.0, P = 0.03) were positively associated
with histologic chorioamnionitis, as was carriage of the
MBL2 54Asp (B allele) (39% versus 25%, OR 1.9, P =
0.04) (Table 2). Although the frequency of the common
TNFRSF6-1377 G/G genotype was higher in women with
histologic chorioamnionitis (0.87 versus 0.73, OR 2.4, P
= 0.03), the variant TNFRSF6-1377A/-670G (AG) haplo-
type (OR 0.4, P = 0.03) and homozygosity for the TGFB1
haplotype -800G/-509T (GT) (OR 0.2, P = 0.03) were neg-
atively associated with chorioamnionitis (Table 2). No
other significant associations with gene variant frequen-
cies were seen in univariate analysis.
For confirmation of independence of association, a multi-
variable model was used including univariate variables
with P values ≤  0.15. This model included the above
genetic variables (Table 2) plus TNF +488 G/A genotype
(25% versus 15%, OR 1.8, P = 0.11) and IL1R1 +970 T/T
(6% versus 14%, OR 0.4, P = 0.08) from Additional file 1.
Multivariable analysis confirmed that carriage of the vari-
ant  IL-10 ATA haplotype [Multivariable Odds Ratio
(MOR) 1.9, P = 0.05)] and MBL2 codon 54Asp (MOR 2.0,
P = 0.04) were independently associated with histologic
chorioamnionitis, while homozygosity for the variant
TGFB1-800G/-509T (GT) haplotype (MOR 0.2, P = 0.04),
and carriage of TNFRSF6-1377A/-670G (AG) haplotype
(MOR 0.4, P = 0.03) remained negatively associated with
histologic chorioamnionitis. The remainder of SNPs
tested showed no significant differences.
To examine the cumulative probability of maintaining a
pregnancy and effect of chorioamnionitis on gestation at
delivery in the overall cohort, Kaplan Meier survival
analysis was performed. Figure 1 shows that chorioamni-
onitis was more common in PTB at earlier gestations
(Breslow-Gehan, Chi square 36 with 1 degree of freedom,
P  ≤  0.001). In addition, the cumulative probability of
maintaining a pregnancy was stratified on the carriage of
IL10 ATA haplotype (Figure 2). Women with this IL10
ATA  haplotype were more likely to deliver at earlier
Table 2: Genes, alleles, haplotypes and genotypes in women with preterm birth before 35 weeks and chorioamnionitis.
Gene Histologic Chorio-
amnionitis n = 69
No Histologic Chorio-
amnionitis n = 112
Univariate analysis OR (95% 
CI) Uncorrected P value
Multivariable analysis OR 
(95% CI), P value
IL10
Allele-819 T 34 (0.50) 37 (0.33) 2.0 (1.0–3.8), 0.03
-592 A 34 (0.50) 37 (0.33) 2.0 (1.0–3.8), 0.03
Haplotype
-1082A/-819T/-592A 34 (0.49) 37 (0.33) 2.0 (1.0–3.8), 0.03 1.8 (1.0–4.0), 0.05
Genotype
-819 C/T 28 (0.41) 28 (0.25) 2.1 (1.0–4-1), 0.03
-592 A/C 28 (0.41) 28 (0.25) 2.1 (1.0–4-1), 0.03
MBL2
Codon 54Asp ('B') 27 (0.39) 28 (0.25) 1.9 (1.0–3.9), 0.04 2.0 (1.0–4.0), 0.04
TNFRSF6
Allele-1377A 9 (0.13) 30 (0.27) 0.4 (0.2–1.0), 0.03
Haplotype
-1377A/-670G 9 (0.13) 30 (0.27) 0.4 (0.2–1.0), 0.03 0.3 (0.2–0.9), 0.03
Genotype
-1377 G/G 60 (0.87) 82 (0.73) 2.4 (1.0–6.3), 0.03
TGFB1
Haplotype
-800G/-509T 2 (0.03) 14 (0.13) 0.2 (0.02–1.0), 0 .03 0.2 (0.04–0.9), 0.04
Homozygosity
Data are presented as number and frequencies of alleles, genotypes and haplotypes.
Univariate analyses were tested using Chi square analysis of 2 × 2 table, and uncorrected P values, Odds Ratio (OR), and 95% Confidence Intervals 
(CI), P values ≤  0.07 are presented.
Multivariable analyses included genetic variables with P values ≤  0.15 using backward step multiple logistic regression. Multivariable model included 
carriage of IL10 ATA, MBL2 codon 54Asp, TNFRS6-1377A/-670G (AG) haplotype, and homozygous TGFB1-800G/-509T, TNF +488 G/A, and IL1R1 
+970 T/T genotypes.
MBL2 codon 54Asp (allele 'B') is a single nucleotide polymorphism in exon 1 codon 54 (Gly/Asp).
TNFRSF6 is the gene symbol for Fas; ns, not significant.BMC Pregnancy and Childbirth 2005, 5:4 http://www.biomedcentral.com/1471-2393/5/4
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gestations (Breslow-Gehan, Chi square 3.5 with 1 degree
of freedom, P = 0.06) (Figure 2). There was no evidence of
the effect of MBL2, TGFB1, or TNFRSF6 SNPs on gestation
of PTB.
Discussion
These results extend prior reports investigating gene poly-
morphisms and the pathogenesis of PTB and chorioamni-
onitis [11]. In this study we found significant positive
associations between the carriage of the IL10 ATA haplo-
type, MBL2 codon 54Asp and histologic chorioamnioni-
tis, and negative associations with TNFRSF6 and TGFB1.
This is the first study to investigate TNFRSF6 and TGFB1
in combination with such a wide range of cytokine SNPs
in histologic acute chorioamnionitis. Also, this is one of
the few studies that have used multivariable and survival
analyses for investigating adverse pregnancy outcomes
such as chorioamnionitis and PTB.
The differences in genotype distribution for IL10  and
MBL2 may be of biologic importance in the pathogenesis
of histologic chorioamnionitis. The function of IL-10 in
pregnancy is of particular interest because of its role in the
homeostatic control of an inflammatory immune
response [23]. Although there have been conflicting
reports the majority suggest that the IL10 ATA promoter
haplotype and alleles comprising the haplotype are asso-
ciated with low protein levels in Caucasians [24]. Low lev-
els of IL-10 have been associated with PTB in rat models
[25]. In a pregnant rhesus monkey model, combined
intra-amniotic and maternal systemic IL-10 administra-
tion inhibited IL-1β -induced preterm uterine contraction
[26]. Survival analysis showed that the IL10 ATA haplo-
type may influence the timing of PTB. IL-10 antagonises
the synthesis and actions of pro-inflammatory cytokines
such as IL-1 [27]. In chorioamnionitis, diminished IL-10
levels may provide an ineffective counter regulatory
response to elevated maternal prostaglandin stimulated
by the pro-inflammatory cytokines IL-1, IL-6 and TNF.
Elevated levels of these pro-inflammatory cytokines in
utero may serve as a maternal [28] and fetal [29] signal for
the onset of premature parturition. The higher proportion
of early PTB in women with the IL10 ATA haplotype may
also be a reflection of failure of tocolysis in the presence
of infection [26]. Our finding that the carriage of the IL10
ATA haplotype is more common in women with histo-
logic chorioamnionitis suggests that this haplotype may
Relationship of chorioamnionitis with gestation at delivery Figure 1
Relationship of chorioamnionitis with gestation at 
delivery. Kaplan-Meier survival estimates in 181 women 
where all gestations proceeded to delivery < 35 weeks. Effect 
of chorioamnionitis (C) versus no chorioamnionitis (NC), P 
< 0.001. Significance was tested using Breslow-Gehan Chi 
square analysis with 1 degree of freedom.
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Relationship of IL10 ATA haplotype with gestation at delivery Figure 2
Relationship of IL10 ATA haplotype with gestation at 
delivery. Kaplan-Meier estimates in 181 women where all 
gestations proceeded to delivery before 35 weeks. Effect of 
IL10 ATA haplotype versus No ATA, P = 0.06. Significance was 
tested using Breslow-Gehan Chi square analysis with 1 
degree of freedom.
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be important in the pathogenesis of histologic chorioam-
nionitis and subsequent PTB.
MBL is an important innate defense molecule active
against a broad range of bacterial, viral, fungal and proto-
zoan pathogens [30]. The MBL2 variant alleles in exon 1
correlate with decreased circulating MBL. The single
nucleotide substitution of an adenine for a guanine in
codon 54 results in replacement of aspartic acid for a gly-
cine in the MBL [31]. Functional MBL is multimeric, con-
sisting of tetramers, pentamers and hexamers of triplets of
the basic MBL peptide. This higher order structure is nec-
essary for high avidity interactions between MBL carbohy-
drate recognition domains and repeated oligosaccharide
moieties on pathogens. The MBL codon 54Asp 'B' allele
disrupts assembly of MBL2 peptide trimers resulting in
lower stability and serum levels [32]. Low serum levels of
MBL and MBL2 genetic variants are associated with infec-
tion in a range of contexts including recurrent infection in
children and adults [6,14], recurrent vulvovaginal candi-
diasis [33], recurrent miscarriage [34] and autoimmunity
in common variable immunodeficiency disease [18]. The
association between MBL2 codon 54Asp and histologic
chorioamnionitis suggests that this allele may result in
low MBL levels, impaired opsonisation and clearance of
pathogens, thus facilitating the development of
chorioamnionitis.
Fas protein is expressed on the surface of many cell types,
such as lymphocytes, epithelial, fibroblasts and certain
endothelial cells, and cytokines [7] and hormones [35]
found in the placental microenvironment may modulate
the immune response by regulating the expression of Fas
and Fas ligand. In this study two polymorphisms in the
Fas (TNFRSF6) gene promoter were studied at positions -
1377 and -670, and the -1377A/-670G (AG) haplotype
was negatively associated with histologic
chorioamnionitis. The -1377G/A is situated at the tran-
scription factor SP-1 binding site [22], and the -670A/G
substitution is located in the enhancer region and abol-
ishes the binding site of the nuclear transcription element
GAS (Gamma Interferon Activation Sequence). The func-
tional significance of these polymorphisms has not been
fully elucidated but they may modulate TNFRSF6 tran-
scription, Fas expression and thus apoptotic and inflam-
matory responses. Recent evidence suggests that cells are
more sensitive to Fas-mediated apoptosis when levels of
Fas expression increase [36]. Apoptotic cell death can
modulate host containment of pathogens [19] and thus
genetically determined variation in Fas-mediated cell
death may influence histologic chorioamnionitis.
Reported studies on gene polymorphisms and adverse
pregnancy outcome have mostly examined SNPs in the
genes encoding the pro-inflammatory cytokines TNF and
IL-1. The TNF promoter -308A allele was associated with
clinical chorioamnionitis in a small number of women
[12]. The in vitro functional data of the effects of the TNF
SNPs are conflicting and may be context dependent and
influenced by strong linkage disequilibrium with other
intra-and-extra-genic polymorphisms (e.g. with lympho-
toxin alpha and classical HLA genes [37], not examined in
this study). In contrast, in this study the TNF-308A could
not be identified as a susceptibility or severity factor for
chorioamnionitis.
SNPs of the IL1 cluster have been examined from different
ethnic groups, in particular IL1B and IL1RN in women
with a history of recurrent pregnancy loss [38], PTB [39],
and in in vitro studies[11]. We did not find associations
between genes of the IL1 cluster or IL1R1 and histologic
chorioamnionitis and this may partly be explained by dif-
ferences in linkage disequilibrium patterns across differ-
ent ethnic populations that can lead to different
association results [40].
Our data support the role of IL10, MBL2 and TNFRSF6
variants in determining the risk of histologic chorioamni-
onitis. However there are limitations to the study, such as
small sample size. The range and number of gene poly-
morphisms examined and analysed by univariate and
multiple logistic regression in this study is notable, but
some correction for multiple analyses is required [41].
The appropriate method still remains a contentious issue.
The Bonferroni method was not conducted, as this is a
conservative method and leads to overcorrection [42].
Also our study is a hypothesis-generating exploratory
study. SNP frequencies in women with and without
chorioamnionitis are available to be included in meta-
analysis to confirm or reject these findings (Additional file
1).
Conclusion
In conclusion, the frequency differences in this study
highlight the significance and biological relevance of
genetic factors, IL-10, MBL and Fas regulation among
women with acute chorioamnionitis and adverse preg-
nancy outcome.
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